Shilajit

No summary available for this substance.

Shilajit

Shilajit is a sticky substance found primarily in the rocks of the Himalayas. It develops over centuries from the slow decomposition of plants. Shilajit is commonly used in ayurvedic medicine and is known to contain various minerals, fulvic acid, and humic substances.

Category
Natural Supplement
Molecular Formula
Variable, primarily consists of fulvic acids, humic acids, and minerals
Mechanism of Action
Exerts effects primarily through antioxidant, anti-inflammatory, and immunomodulatory activities. The fulvic acid content helps in the transportation of nutrients into deep tissues and enhances the bioavailability of other substances.
Evidence Grade
C - Unclear scientific evidence for this use

Other Names

  • Mineral Pitch
  • Jew's Pitch
  • Asphaltum

Primary Benefits

  • Energy boost
  • Memory enhancement
  • Anti-aging properties
  • Anemia improvement
  • Anti-inflammatory and antioxidant properties

Recommended Dosage

Adults 300 to 500 mg per day
Children Not recommended for children

Side Effects

  • Allergic reactions
  • Dizziness
  • Increased heart rate
  • Skin rash

Precautions

  • Pregnant or breastfeeding women should avoid
  • People with heart disease should use with caution
  • People with gout should avoid

Interactions

  • Diuretics
  • Diabetes medications
  • Hypertension medications

Key References

  • 'Shilajit: A panacea for high-altitude problems', International Journal of Ayurveda Research
  • 'Therapeutic Potential of Shilajit: An Ancient Remedy from Nature', International Journal of Toxicological and Pharmacological Research
Dr. Peter Attia: Supplements for Longevity & Their Efficacy
Supplements, Lifestyle, and Strategies for Longevity and Optimal Health 1:42:16 0
“I use a quality whey protein as a protein replacement that kind of thing and I've played around with various things like Sheila G and you know sometimes get the sense that it's having an effect but then I'll stop taking it for long periods of time”

No comments yet.

View all comments (0)